Baird Initiates Coverage On Vaxxinity with Outperform Rating, Announces Price Target of $7
Portfolio Pulse from Benzinga Newsdesk
Baird analyst Joel Beatty has initiated coverage on Vaxxinity (NASDAQ:VAXX) with an Outperform rating and a price target of $7.
September 08, 2023 | 8:39 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vaxxinity has received an Outperform rating from Baird with a price target of $7.
The Outperform rating from Baird indicates a positive outlook for Vaxxinity. The price target of $7 suggests that Baird expects the stock to rise in the short term. This could potentially lead to an increase in the stock's price as investors react to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100